TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27563883

Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT) - 1 mg/day of estradiol valerate plus 5 mg/10 day of medroxiprogesterone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24499510

Group type: EXPERIMENTAL
Intervention: Microdrop insemination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open insemination
Number of subjects: 0
Study: 23917935

Group type: EXPERIMENTAL
Intervention: Chlorhexidine hygiene with toothbrushing
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (gel with the same color and consistency and toothbrushing)
Number of subjects: 52
Study: 19918203

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg daily for 12 months)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 18276619

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-Xa levels > 0.9 IU/mL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activated Clotting Time (ACT) > 325 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activated Clotting Time (ACT) < 325 s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-Xa levels and covariate-adjusted incidence of death, myocardial infarction, or revascularization
Number of subjects: 0
Study: 15819677

Group type: EXPERIMENTAL
Intervention: Indirect hemagglutination test (IHA)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Combinations of two tests used in parallel (IHA plus ELISA or IHA plus IFA)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Single IHA testing
Number of subjects: 400

Group type: COMPARATOR
Intervention: Single ELISA or single IFA testing
Number of subjects: 400
Study: 14623061

Group type: EXPERIMENTAL
Intervention: 2.5 mg tibolone
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 1.25 mg tibolone
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 2 mg estradiol plus 1 mg norethindrone acetate
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Highest quartile of leptin levels
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Baseline serum leptin
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Adjustment for BMI and fat mass
Number of subjects: 121
Study: 11003744

Group type: EXPERIMENTAL
Intervention: Platelet activating factor antagonist (low-dose 10 mg or high-dose 100 mg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Bilateral internal thoracic artery grafting
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Single internal thoracic artery grafting
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Coronary endarterectomy
Number of subjects: 150
Study: 8977781

Group type: EXPERIMENTAL
Intervention: Warm lignocaine (37 degrees C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cold lignocaine (room temperature)
Number of subjects: 60
Study: 1443350

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg/day for 10 days)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 49
Study: 6536515

Group type: EXPERIMENTAL
Intervention: Midazolam (Hypnovel, Roche)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diazepam in propylene glycol (Valium, Roche)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both drugs (Midazolam and Diazepam)
Number of subjects: 40
Study: 3108780

Group type: EXPERIMENTAL
Intervention: Active device
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 20
Study: 31126845

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus evofosfamide
Number of subjects: 209

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 209
Study: 29650408

Group type: EXPERIMENTAL
Intervention: OCS Lung device
Number of subjects: 370

Group type: COMPARATOR
Intervention: Cold storage at 4°C (control)
Number of subjects: 370
Study: 27617742

Group type: EXPERIMENTAL
Intervention: Lay health worker (LHW) intervention with reminder calls and resource list
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group receiving only a list of resources by mail
Number of subjects: 600
Study: 23650913

Group type: EXPERIMENTAL
Intervention: Prophylactic endoscopic injection sclerotherapy (EIS)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (observed conservatively)
Number of subjects: 27
Study: 22721975

Group type: EXPERIMENTAL
Intervention: Vibrotactile biofeedback training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no biofeedback)
Number of subjects: 20
Study: 20507401

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (250 mg) every 12 hours for 6 months
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo every 12 hours for 6 months
Number of subjects: 32
Study: 18778135

Group type: EXPERIMENTAL
Intervention: Adapted motivational interviewing (AMI) group (1 individual AMI session + self-help handbook)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Adapted motivational interviewing (AMI) group
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (handbook only)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups (AMI and control)
Number of subjects: 108
Study: 15721701

Group type: EXPERIMENTAL
Intervention: Hansatome microkeratome
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: IntraLase femtosecond laser
Number of subjects: 9
Study: 15000443

Group type: EXPERIMENTAL
Intervention: Blood beta‐HBA monitoring (group 1)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Urine ketone bodies monitoring (group 2)
Number of subjects: 33
Study: 10733017

Group type: EXPERIMENTAL
Intervention: Leuprorelin 3.75 mg (n=33)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Lynestrenol 5 mg (n=23)
Number of subjects: 56
Study: 8817830

Group type: EXPERIMENTAL
Intervention: Plasmodium falciparum circumsporozoite protein vaccine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Hepatitis B vaccine (control)
Number of subjects: 76
Study: 1306086

Group type: EXPERIMENTAL
Intervention: Diapulse therapy (pulsed electromagnetic energy of 27.12 MHz frequency)
Number of subjects: 0
Study: 3908316

Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 29953338

Group type: COMPARATOR
Intervention: ClinPro XT Varnish (XTV)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Duraphat (DUR)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Desensibilize Nano P (NP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: ClinPro White Varnish (CWV)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 55
Study: 29146277

Group type: EXPERIMENTAL
Intervention: Lowering LDL cholesterol with simvastatin/ezetimibe
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher baseline CRP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher baseline LDL cholesterol
Number of subjects: 0
Study: 27825007

Group type: EXPERIMENTAL
Intervention: Tailored dose-dense chemotherapy (4 cycles of leukocyte nadir-based tailored and dose-dense epirubicin and cyclophosphamide every 2 weeks followed by 4 cycles of tailored dose-dense docetaxel every 2 weeks)
Number of subjects: 2017

Group type: COMPARATOR
Intervention: Standard 3-weekly chemotherapy (3 cycles of fluorouracil and epirubicin-cyclophosphamide every 3 weeks followed by 3 cycles of docetaxel every 3 weeks)
Number of subjects: 2017

Group type: EXPERIMENTAL
Intervention: Tailored dose-dense chemotherapy
Number of subjects: 2017

Group type: COMPARATOR
Intervention: Standard 3-weekly chemotherapy
Number of subjects: 2017
Study: 24423358

Group type: EXPERIMENTAL
Intervention: TSH-suppressive L-T4 doses
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Replacement L-T4 doses
Number of subjects: 79

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 79
Study: 21681818

Group type: EXPERIMENTAL
Intervention: Virtual reality-based memory training
Number of subjects: 44

Group type: COMPARATOR
Intervention: Therapist-led memory training
Number of subjects: 44
Study: 20686332

Group type: EXPERIMENTAL
Intervention: Sulbactomax (1.5 g)
Number of subjects: 8
Study: 17908630

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation
Number of subjects: 0
Study: 16109568

Group type: EXPERIMENTAL
Intervention: Silicone urinary catheters
Number of subjects: 60

Group type: COMPARATOR
Intervention: Latex urinary catheters
Number of subjects: 60
Study: 12426862

Group type: EXPERIMENTAL
Intervention: Alfuzosin, doxazosin, tamsulosin, terazosin (α1‐adrenoceptor antagonists)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower dosing regimen of α1‐adrenoceptor antagonists
Number of subjects: 0
Study: 11015162

Group type: EXPERIMENTAL
Intervention: Azithromycin, 1200 mg once weekly (n = 321)
Number of subjects: 643

Group type: COMPARATOR
Intervention: Placebo (n = 322)
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 643

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 643
Study: 9001826

Group type: EXPERIMENTAL
Intervention: 50-microgram/d estradiol
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: 100-microgram/d estradiol
Number of subjects: 273

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 273
Study: 1360557

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg daily + sotalol
Number of subjects: 2035

Group type: COMPARATOR
Intervention: Placebo + sotalol
Number of subjects: 2035
Study: 2865914

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (50 μg)
Number of subjects: 30
Study: 30820995

Group type: EXPERIMENTAL
Intervention: Nomogram predicting IHA
Number of subjects: 379
Study: 29723754

Group type: EXPERIMENTAL
Intervention: Dense hierarchical figures
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Sparse hierarchical figures
Number of subjects: 1
Study: 28700587

Group type: EXPERIMENTAL
Intervention: Participatory community and health system intervention (client service charter and quality-improvement process)
Number of subjects: 2085

Group type: EXPERIMENTAL
Intervention: Participatory community and health system intervention
Number of subjects: 2085
Study: 26828335

Group type: EXPERIMENTAL
Intervention: Multidimensional nursing form intervention coordinated by nurses after attending ad hoc teaching sessions
Number of subjects: 0
Study: 23269114

Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extrapolated ERSPC results
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screen-detected cases in the US
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ERSPC results
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm screening in PLCO trial
Number of subjects: 0
Study: 21569044

Group type: EXPERIMENTAL
Intervention: S-303 treated RBCs
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control RBCs
Number of subjects: 27
Study: 18093108

Group type: EXPERIMENTAL
Intervention: Quality circles with traditional anonymous feedback
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Quality circles with open benchmark
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: High medication guideline adherence
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Use of theophylline
Number of subjects: 256
Study: 16239318

Group type: EXPERIMENTAL
Intervention: Flu‐Met plus oral contraceptive
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Flu‐Met plus transdermal contraceptive
Number of subjects: 31
Study: 12672915

Group type: EXPERIMENTAL
Intervention: Egg (640 mg/d additional dietary cholesterol)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (0 mg/d additional dietary cholesterol)
Number of subjects: 40
Study: 10751252

Group type: EXPERIMENTAL
Intervention: In vivo exposure to S. pyogenes exotoxins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TCR expression analysis of CD8+ MBP-reactive T cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokine mRNA quantification of mononuclear cells
Number of subjects: 0
Study: 9394653

Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Spiral CT
Number of subjects: 25
Study: 8378157

Group type: EXPERIMENTAL
Intervention: Electronic Dental Anesthesia (EDA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Traditional Local Anesthesia
Number of subjects: 27
Study: 3946247

Group type: EXPERIMENTAL
Intervention: pindolol (10 or 20 mg daily) and hydrochlorothiazide (50 mg daily)
Number of subjects: 34
Study: 30497467

Group type: EXPERIMENTAL
Intervention: Methadone Maintenance Treatment Programme (MMTP)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Multi-sectorial approach to managing OUD
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Time-limit enforcement on client engagement
Number of subjects: 17
Study: 26731696

Group type: EXPERIMENTAL
Intervention: Norfloxacin 800 mg/day for 10 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 23666018

Group type: EXPERIMENTAL
Intervention: Exercise (EX) - cycling tailored to expend 400 kcal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition - time-matched no exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 0
Study: 24370797

Group type: EXPERIMENTAL
Intervention: Aortic root venting (Group I)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Pulmonary arterial venting (Group II)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Pulmonary artery venting
Number of subjects: 301
Study: 20942646

Group type: EXPERIMENTAL
Intervention: RG7128 monotherapy for 2 weeks (1500 mg twice daily)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: RG7128 in combination with SOC for 4 weeks (1000 mg and 1500 mg twice daily)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (SOC only)
Number of subjects: 117
Study: 18806709

Group type: EXPERIMENTAL
Intervention: Probiotics (PBs) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 16784998

Group type: EXPERIMENTAL
Intervention: CPR+AED
Number of subjects: 20396

Group type: COMPARATOR
Intervention: CPR alone
Number of subjects: 20396
Study: 14558182

Group type: EXPERIMENTAL
Intervention: Medication advice and reviews by specialists in clinical pharmacology and cardiology.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 80
Study: 10906167

Group type: EXPERIMENTAL
Intervention: Nephrology service (n = 114)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Internal medicine service (n = 105)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Nephrology service
Number of subjects: 161

Group type: COMPARATOR
Intervention: Internal medicine service
Number of subjects: 161
Study: 8813265

Group type: EXPERIMENTAL
Intervention: Cultured autologous epithelial autografts
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (standard burn wound coverage)
Number of subjects: 22
Study: 7925067

Group type: EXPERIMENTAL
Intervention: Fansidar (Hoffman-LaRoche)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Falcidin (Cosmos)
Number of subjects: 2
Study: 2899439

Group type: EXPERIMENTAL
Intervention: Celiprolol (400 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Atenolol (100 mg)
Number of subjects: 16
Study: 31126278

Group type: EXPERIMENTAL
Intervention: ACTI-BREAK intervention (3 x 5-minute moderate-intensity breaks daily)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: ACTI-BREAK intervention
Number of subjects: 374
Study: 28409771

Group type: EXPERIMENTAL
Intervention: Early cataract surgery (within the first week after trauma)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Late cataract surgery (from the first to second month after trauma)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Early cataract surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Late cataract surgery
Number of subjects: 60
Study: 25834589

Group type: COMPARATOR
Intervention: Calcium hydroxide lining paste (Dycal) - Control group A
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ProRoot MTA (standard double‐visit method) - Group B
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ProRoot MTA (single‐visit method) - Group C
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide injectable paste (Multi‐Cal) - Group D
Number of subjects: 8
Study: 23306175

Group type: EXPERIMENTAL
Intervention: Sonography-guided supine PCNL (group A)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard fluoroscopic-guided prone PCNL (group B)
Number of subjects: 92
Study: 20632097

Group type: EXPERIMENTAL
Intervention: Live View Video Capsule Endoscopy (VCE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard clinical assessment (Control)
Number of subjects: 24
Study: 19056590

Group type: COMPARATOR
Intervention: 0 g whole egg protein
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 5 g whole egg protein
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 g whole egg protein
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 g whole egg protein
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 40 g whole egg protein
Number of subjects: 6
Study: 17174630

Group type: EXPERIMENTAL
Intervention: Sirolimus stents
Number of subjects: 205

Group type: COMPARATOR
Intervention: Paclitaxel stents
Number of subjects: 205
Study: 15150632

Group type: EXPERIMENTAL
Intervention: Non-brushing (NB) side
Number of subjects: 12

Group type: COMPARATOR
Intervention: Brushing (B) side
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall comparison of SUL, GI, and BOP scores
Number of subjects: 12
Study: 11799544

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy and physician advice
Number of subjects: 381
Study: 9730426

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 82

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Tacrolimus with antithymocyte globulin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Cyclosporine with antithymocyte globulin
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Tacrolimus without antithymocyte globulin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Cyclosporine without antithymocyte globulin
Number of subjects: 82
Study: 7756587

Group type: EXPERIMENTAL
Intervention: Cytotoxic agents (cyclophosphamide or chlorambucil)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Symptomatic treatment or corticosteroids (control group)
Number of subjects: 228
Study: 2111195

Group type: EXPERIMENTAL
Intervention: Nitrogen intake of 0.2 g kg body-weight-1 24 h-1
Number of subjects: 39

Group type: COMPARATOR
Intervention: No nitrogen intake
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nitrogen intake of 0.3 g kg body-weight-1 24 h-1
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nitrogen intake of 0.1 g kg body-weight-1 24 h-1
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Nitrogen intake of 0.0 g kg body-weight-1 24 h-1
Number of subjects: 39
Study: 761953

Group type: EXPERIMENTAL
Intervention: 100 mg nomifensine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 15 mg racemic amphetamine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30964707

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (PPARγ agonist)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 28793980

Group type: EXPERIMENTAL
Intervention: Peer-led, social media-delivered safer sex intervention
Number of subjects: 196

Group type: COMPARATOR
Intervention: Existing online sexual health website (control)
Number of subjects: 196
Study: 26061799

Group type: EXPERIMENTAL
Intervention: Energy Balance for Kids with Play (EB4K with Play) intervention
Number of subjects: 879

Group type: EXPERIMENTAL
Intervention: Energy Balance for Kids with Play (EB4K with Play) intervention (fourth-grade students)
Number of subjects: 879

Group type: EXPERIMENTAL
Intervention: Energy Balance for Kids with Play (EB4K with Play) intervention (third-grade students)
Number of subjects: 879

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 879
Study: 23279750

Group type: EXPERIMENTAL
Intervention: 12-week group-based PT program (six 1 h sessions, eight patients per group)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Usual PT care (two individual visits with a physical therapist)
Number of subjects: 376
Study: 20817484

Group type: EXPERIMENTAL
Intervention: GRIP+TAU
Number of subjects: 46

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 46
Study: 18372267

Group type: EXPERIMENTAL
Intervention: Collagen/oxidized regenerated cellulose/antimicrobial matrix
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 49
Study: 16516824

Group type: EXPERIMENTAL
Intervention: Haloperidol (1 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nalbuphine (5 mg, intravenous)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nalbuphine (5 mg, intravenous) with neuroleptics
Number of subjects: 0
Study: 14618062

Group type: EXPERIMENTAL
Intervention: Reversed polarity monophasic shock
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard polarity monophasic shock
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reversed polarity biphasic shock
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard polarity biphasic shock
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reversed polarity for elevated biphasic DFT (>or=15 J)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard polarity for elevated biphasic DFT (>or=15 J)
Number of subjects: 30
Study: 10740150

Group type: EXPERIMENTAL
Intervention: Intravenous felodipine 0.3 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oral felodipine 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2006757

Group type: EXPERIMENTAL
Intervention: bezafibrate 400 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: simvastatin 10-40 mg/day
Number of subjects: 36
Study: 6128281

Group type: EXPERIMENTAL
Intervention: Tiopronin 600 mg daily
Number of subjects: 165